Shangxiang L. Chen
651# East Dongfeng Road
Guangzhou, 510000, China
Guangzhou, 510000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer.
Journal: Nanoscale
Published: September 10, 2025
Associations of all-cause mortality with admission blood pressure variability during multiple hospitalizations in acute decompensated heart failure
Journal: Zhonghua xin xue guan bing za zhi
Published: April 14, 2023
Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification.
Journal: Pharmacological research
Published: September 07, 2022
Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer via the reversal of pancreatic stellate cell desmoplasia by targeting the AP4/galectin-1 pathway.
Journal: Biomaterials science
Published: September 02, 2022
GLUT1 Regulates the Tumor Immune Microenvironment and Promotes Tumor Metastasis in Pancreatic Adenocarcinoma via ncRNA-mediated Network.
Journal: Journal of Cancer
Published: February 18, 2022
Peripheral blood monocytes predict clinical prognosis and support tumor invasiveness through NF-κB-dependent upregulation of Snail in pancreatic cancer.
Journal: Translational cancer research
Published: June 08, 2021
Bioinformatics-Based Identification of Tumor Microenvironment-Related Prognostic Genes in Pancreatic Cancer.
Journal: Frontiers in genetics
Published: November 24, 2020
TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
Journal: Biochemical pharmacology
Published: February 13, 2020
Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
Journal: The Journal of pathology
Published: January 17, 2020
Last Updated: 09/26/2026